Bionik Laboratories Corp. (BNKL)

Bionik Laboratories Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 12, 2026	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Market Capitalization	0	3	2	13	9	11
Market Cap Growth	-100.00%	26.29%	-82.73%	35.07%	-14.49%	50.08%
Enterprise Value	-	4	8	16	8	14
Last Close Price	0.00	0.40	0.38	2.50	1.85	4.25
PS Ratio	0.00	1.55	1.74	10.74	4.41	3.42
PB Ratio	0.00	-1.70	0.76	3.91	0.71	0.41
P/TBV Ratio	-	-	0.76	-	12.15	16.52
EV/Sales Ratio	-	2.20	5.95	13.60	3.56	4.39
Debt / Equity Ratio	-1.47	-1.47	-	1.13	0.16	-
Net Debt / Equity Ratio	-1.21	-1.21	-0.68	0.95	-0.01	-0.02
Net Debt / EBITDA Ratio	-0.42	-0.42	0.43	-0.52	0.02	0.05
Net Debt / FCF Ratio	-0.58	-0.58	0.48	-0.67	0.02	0.05
Asset Turnover	0.45	0.45	0.19	0.09	0.09	0.11
Inventory Turnover	0.42	0.42	0.15	0.12	0.44	1.56
Quick Ratio	0.38	0.38	1.52	0.26	0.65	0.62
Current Ratio	1.20	1.20	3.07	0.84	1.22	1.15
Return on Equity (ROE)	-768.84%	-768.84%	-335.30%	-164.12%	-122.86%	-44.10%
Return on Assets (ROA)	-74.23%	-74.23%	-44.32%	-28.18%	-28.37%	-20.01%
Return on Capital Employed (ROCE)	-453.30%	-453.30%	-149.90%	-131.20%	-81.30%	-34.60%
Earnings Yield	-38046338.46%	-176.91%	-470.15%	-106.25%	-263.58%	-95.11%
FCF Yield	-26123138.46%	-121.47%	-187.91%	-36.07%	-97.18%	-84.10%
Buyback Yield / Dilution	-18.13%	-18.13%	-13.95%	-15.10%	-88.55%	-251.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.